Related Experiment Video
Updated: Mar 28, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Treatment of infantile subglottic hemangioma with oral propranolol
Cai-Fu Wang1, Ying-Shuo Wang1, Yue-Feng Sun2
1Departments of Pulmonology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Insights
Oral propranolol effectively treats infantile subglottic hemangioma (SH), resolving symptoms rapidly. This study suggests propranolol as a recommended first-line therapy for infants requiring intervention for SH.
Area of Science:
- Pediatric Otolaryngology
- Neonatal Medicine
- Pharmacology
Background:
- Infantile subglottic hemangioma (SH) presents a significant clinical challenge, potentially causing severe airway obstruction.
- Current treatment strategies for SH lack consensus and carry risks of adverse effects.
Observation:
- Four infants diagnosed with subglottic hemangioma were treated with oral propranolol.
- Clinical monitoring documented the infants' response to the therapeutic intervention.
Findings:
- Oral propranolol administration led to rapid symptom resolution within two days for all treated infants.
- Complete recovery was observed in all cases following propranolol treatment for SH.
Implications:
- Propranolol demonstrates significant efficacy as a treatment for infantile subglottic hemangioma.
- The findings support the use of propranolol as a first-line therapeutic option for SH requiring intervention.
Abstract:
Infantile subglottic hemangioma (SH) can cause biphasic stridor, respiratory distress and even life-threatening airway compromise. Treatment of SH in infants has traditionally been characterized as a challenging situation with multiple therapeutic options without consensus as to which one is the best and with risks of severe side-effects. Four infants with SH were treated with propranolol. Treatment with oral propranolol resulted in resolution of symptoms within 2 days, followed by complete recovery. Propranolol appears to be an effective treatment for SH and should be used as a first-line treatment for SH when intervention is required.
More Related Videos
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drug Delivery: Enteral Route
Mitral Stenosis III: Medical Management
Angina IV: Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

